Caris Life Sciences®
Caris Life Sciences® is a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer that is actively developing and commercializing innovative solutions to transform healthcare.
Caris Discovery uncovers novel tumor targets directly on Caris-profiled tissue via proprietary proteomic platforms, parallel wet lab & multimodal analysis, and cutting-edge informatics to analyze and further unravel the molecular complexity of disease.
ADC targets are comprehensively validated using the Caris-profiled tumor repository and matched longitudinal clinical outcomes.
